Hida T - Search Results

1

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.

Ahn MJ, Tsai CM, Shepherd FA, Bazhenova L, Sequist LV, Hida T, Yang JCH, Ramalingam SS, Mitsudomi T, Jänne PA, Mann H, Cantarini M, Goss G. Ahn MJ, et al. Among authors: hida t. Cancer. 2019 Mar 15;125(6):892-901. doi: 10.1002/cncr.31891. Epub 2018 Dec 4. Cancer. 2019. PMID: 30512189 Free article. Clinical Trial.

2

Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.

Takahashi T, Carbone D, Takahashi T, Nau MM, Hida T, Linnoila I, Ueda R, Minna JD. Takahashi T, et al. Among authors: hida t. Cancer Res. 1992 Apr 15;52(8):2340-3. Cancer Res. 1992. PMID: 1559236

3

Preferential expression of c-kit protooncogene transcripts in small cell lung cancer.

Sekido Y, Obata Y, Ueda R, Hida T, Suyama M, Shimokata K, Ariyoshi Y, Takahashi T. Sekido Y, et al. Among authors: hida t. Cancer Res. 1991 May 1;51(9):2416-9. Cancer Res. 1991. PMID: 1707753

4

Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.

Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T. Takahashi T, et al. Among authors: hida t. Cancer Res. 1989 May 15;49(10):2683-8. Cancer Res. 1989. PMID: 2540905

5

Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.

Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T. Hida T, et al. Cancer Res. 1989 Sep 1;49(17):4785-90. Cancer Res. 1989. PMID: 2547517

6

Ectopic expression of c-kit in small-cell lung cancer.

Hida T, Ueda R, Sekido Y, Hibi K, Matsuda R, Ariyoshi Y, Sugiura T, Takahashi T, Takahashi T. Hida T, et al. Int J Cancer Suppl. 1994;8:108-9. doi: 10.1002/ijc.2910570723. Int J Cancer Suppl. 1994. PMID: 7515024

7

Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.

Sekido Y, Takahashi T, Ueda R, Takahashi M, Suzuki H, Nishida K, Tsukamoto T, Hida T, Shimokata K, Zsebo KM, et al. Sekido Y, et al. Among authors: hida t. Cancer Res. 1993 Apr 1;53(7):1709-14. Cancer Res. 1993. PMID: 7680956

8

Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response.

Hida T, Kuwabara M, Ariyoshi Y, Takahashi T, Sugiura T, Hosoda K, Niitsu Y, Ueda R. Hida T, et al. Cancer. 1994 Mar 1;73(5):1377-82. doi: 10.1002/1097-0142(19940301)73:5<1377::aid-cncr2820730511>3.0.co;2-n. Cancer. 1994. PMID: 8111704 Clinical Trial.

9

Synchronous lung cancer presenting with small cell carcinoma and adenocarcinoma.

Hida T, Ariyoshi Y, Sugiura T, Suyama M, Takahashi T, Ueda R. Hida T, et al. Chest. 1993 Nov;104(5):1602-4. doi: 10.1378/chest.104.5.1602. Chest. 1993. PMID: 8222832 Review.

10

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T. Hida T, et al. Cancer Res. 1998 Sep 1;58(17):3761-4. Cancer Res. 1998. PMID: 9731479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

655 results

Search Page